Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy × Pemetrexed × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 51 Lung Neoplasms 25 Neoplasm Metastasis 8 Neoplasms 6 Colorectal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Carcinoma 4 Rectal Neoplasms 3 Mesothelioma, Malignant 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pancreatic Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Pathologic Processes 1 Pathologic Complete Response 1 Ovarian Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡